
Johnson & Johnson worried about losses from China tariffs despite projecting $700 million in profits
Johnson & Johnson's CEO said President Trump's tariffs on pharmaceuticals could cause a problem for drug supply chains. During an investor call, CEO Joaquin Duato told his colleagues that they should work with the Trump administration to …